Can the CSL share price push back above $300?
Image source: Getty Images
The CSL Ltd (ASX: CSL) share price hit a 52-week closing high of $312.15 on 23 July before turning to the downside.
Shares are down more than 6% in the past month, currently fetching $286.28 at the close on Monday.
Despite this volatility, some analysts believe there’s a strong case for a recovery, with a path that could see the biotech giant’s share price climb back above $300.
Why is CSL’s share price down?
The CSL share price was heavily sold after its FY24 results. Added to that, its FY25 guidance came in weaker than expected, which saw investors unload shares en masse in the following weeks.
The ASX healthcare share now expects 5–7% revenue growth this year, which could pull down to 10–13% growth in…
